Moleculin Biotech, Inc. Earnings Per Share (Basic)
Moleculin Biotech, Inc. (MBRX) reported Earnings Per Share (Basic) of -$1.40 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Moleculin Biotech, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.40.
- Moleculin Biotech, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$3.54.
- Moleculin Biotech, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.68.
- Moleculin Biotech, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$28.68.
- Moleculin Biotech, Inc. earnings per share, basic for fiscal 2025 was -$28.42.
- Moleculin Biotech, Inc. earnings per share, basic for fiscal 2024 was -$189.14.
- Moleculin Biotech, Inc. earnings per share, basic for fiscal 2023 was -$15.07.
- Moleculin Biotech, Inc. earnings per share, basic for fiscal 2022 was -$15.22.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.40 10-Q · filed 2026-08-13 | -$4.60 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$3.54 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$28.42 10-K · filed 2026-03-18 | |||||||
| 2025-09-30 | -$0.68 10-Q · filed 2025-11-13 | -$2.36 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$28.68 10-Q · filed 2026-08-13 | -$0.49 10-Q · filed 2025-08-12 | -$47.61 10-Q · filed 2026-08-13 | -$1.13 10-Q · filed 2025-08-12 | ||||
| 2025-03-31 | -$15.80 10-Q · filed 2026-05-14 | -$0.69 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | -$189.14 10-K · filed 2026-03-18 | -$6.32 10-K · filed 2025-03-21 | ||||||
| 2024-09-30 | -$1.89 10-Q · filed 2025-11-13 | -$2.85 10-Q · filed 2024-11-08 | -$6.69 10-Q · filed 2025-11-13 | -$6.83 10-Q · filed 2024-11-08 | ||||
| 2024-06-30 | -$2.37 10-Q · filed 2025-11-13 | -$1.70 10-Q · filed 2024-08-13 | -$4.97 10-Q · filed 2025-11-13 | -$3.71 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | -$2.61 10-Q · filed 2025-11-13 | -$2.02 10-Q · filed 2024-05-10 | ||||||
| 2023-12-31 | -$15.07 10-K · filed 2025-03-21 | |||||||
| 2023-09-30 | -$2.82 10-Q · filed 2024-11-08 | -$0.19 10-Q · filed 2023-11-13 | -$9.94 10-Q · filed 2024-11-08 | -$0.66 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | -$3.02 10-Q · filed 2024-08-13 | -$0.20 10-Q · filed 2023-08-10 | -$7.13 10-Q · filed 2024-08-13 | -$0.48 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | -$4.13 10-Q · filed 2024-05-10 | -$0.28 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | -$15.22 10-K · filed 2024-03-22 | -$1.01 10-K · filed 2023-03-22 | ||||||
| 2022-09-30 | -$0.30 10-Q · filed 2023-11-13 | -$0.78 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | -$0.24 10-Q · filed 2023-08-10 | -$0.48 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$0.24 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | -$0.59 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | -$0.15 10-Q · filed 2022-11-10 | -$0.50 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | -$0.15 10-Q · filed 2022-08-12 | -$0.35 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.20 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |